HCPCS Code Detail Logo

HCPCS Codes Similar to M1447

HCPCS Codes Similar to “M1447” Code.
Patients with an active diagnosis of bipolar disorder any time prior to the end of the measure assessment period

G0032
Two or more antipsychotic prescriptions ordered for patients who had a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or between january 1 of the year prior to the measurement period and the index prescription start date (ipsd) for antipsychotics
Code added date: 20220101
Code effective date: 20220101
G9394
Patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period
Code added date: 20150101
Code effective date: 20150101
G9717
Documentation stating the patient has had a diagnosis of bipolar disorder
Code added date: 20170101
Code effective date: 20240101
M1448
Patients with an active diagnosis of personality disorder any time prior to the end of the measure assessment period
Code added date: 20260101
Code effective date: 20260101
M1449
Patients with an active diagnosis of schizophrenia or psychotic disorder any time prior to the end of the measure assessment period
Code added date: 20260101
Code effective date: 20260101
M1451
Patients with an active diagnosis of pervasive developmental disorder any time prior to the end of the measure assessment period
Code added date: 20260101
Code effective date: 20260101
G8561
Patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure
Code added date: 20100101
Code effective date: 20100101
G9507
Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs)
Code added date: 20160101
Code effective date: 20160101
G9667
Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)
Code added date: 20160101
Code effective date: 20170101
G9668
Documentation of medical reason (s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)
Code added date: 20160101
Code effective date: 20160101
G9781
Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)
Code added date: 20170101
Code effective date: 20230101
G9799
Patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure period
Code added date: 20170101
Code effective date: 20210101
M1446
Patients who died any time prior to the end of the measure assessment period
Code added date: 20260101
Code effective date: 20260101
G2077
Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical, nutrition and psychiatric treatment needs and goals; may be informed by administration of a standardized, evidence-based assessment, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code
Code added date: 20200101
Code effective date: 20260101